https://www.dsij.in/dsijarticledetail/this-mid-cap-multibagger-pharma-company-signs-moa-with-iit-kanpur-for-novel-gene-therapy-assets-31172
0
0
6/19/23 at 9:11am
Organization
Dsij.in
Author
Siddharth Mane
The company delivered exceptional returns of 251 per cent over the past 3 years, while over the past 5 years, it provided remarkable returns of 242 per cent.
Create an account
or login to join the discussion